The world’s largest international registry of clinical trials ClinicalTrials.gov has published in the public domain the results of testing TOR, the non-invasive electromagnetic therapy device created by scientists from the Russian GRANIT Concern for the prevention and treatment of COVID-19.
Trial registration number is NCT05220579.
ClinicalTrials.gov is operated by the US National Library of Medicine (NLM) at the National Institutes of Health. The information published in this registry is carefully checked for reliability, accuracy, relevance and legal ownership of the owner, as well as compliance with the research methodology to the strictest international standards.
The international medical database and clinical trials database ClinicalTrials.gov is used by doctors around the world and has over 329,000 registered trials from 209 countries. Leading peer-reviewed medical publishers check clinical trials on ClinicalTrials.gov before publishing information in their journals.
Now the results of clinical trials of the TOR apparatus with a detailed description of the methodology and sequence of their conduct have also been included in the registry.
In particular, 236 patients participated in the study: men and women over 18 years of age with COVID-19 coronavirus infection. These patients with a moderate course of the disease did not require mechanical ventilation at the time of enrollment in the study. Infection with the SARS-CoV-2 virus was confirmed by PCR testing (nasopharyngeal and oropharyngeal swab).
Patients of the test group were exposed to the TOR device for at least five consecutive days for four hours daily in the mode of 15 minutes of exposure + 15 minutes of break in combination with standard therapy. Patients of the placebo group were in a room with the TOR device turned off and received standard therapy.
In turn, the control group received only standard therapy, which was prescribed in accordance with the recommended treatment regimens presented in the current version of the Interim Guidelines of the Russian Ministry of Health “Prevention, diagnosis and treatment of coronavirus infection (COVID-19)” No. 9 dated 26.10.2020)”.
As a result of the clinical study, it was found that “the TOR non-invasive electromagnetic therapy device is safe when used as intended; it is effective as an adjuvant or immune response enhancer in combination with standard COVID-19 treatments to accelerate the elimination of the SARS-CoV-2 virus from the nasopharynx.